Report Detail
Global Poultry Live Attenuated Vaccine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4678945 |
- 26 February, 2026 |
- Global |
- 106 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Poultry Live Attenuated Vaccine market size was valued at US$ 2319 million in 2025 and is forecast to a readjusted size of US$ 2851 million by 2032 with a CAGR of 3.0% during review period.
Poultry live attenuated vaccines are a type of vaccine used in the poultry industry to protect birds from various infectious diseases. Live attenuated vaccines contain weakened or modified forms of the pathogen that causes the disease, allowing the bird"s immune system to develop a protective response without causing severe illness.
This report is a detailed and comprehensive analysis for global Poultry Live Attenuated Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Poultry Live Attenuated Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Poultry Live Attenuated Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Poultry Live Attenuated Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Poultry Live Attenuated Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Poultry Live Attenuated Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Poultry Live Attenuated Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include MERCK, Boehringer Ingelheim, CEVA, ZOETIS, Vaxxinova, ELANCO, QYH BIOTECH, PULIKE, PHIBRO ANIMAL HEALTH CORPORATION, HARBIN PHARMACEUTICAL GROUP, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Poultry Live Attenuated Vaccine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
NDV
Marek ' s Disease
IBD
Infectious Bronchitis
Influenza
Other
Market segment by Application
Chicken
Other Poultry
Major players covered
MERCK
Boehringer Ingelheim
CEVA
ZOETIS
Vaxxinova
ELANCO
QYH BIOTECH
PULIKE
PHIBRO ANIMAL HEALTH CORPORATION
HARBIN PHARMACEUTICAL GROUP
MEVAC
VENKY’S
Dechra
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Poultry Live Attenuated Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Poultry Live Attenuated Vaccine, with price, sales quantity, revenue, and global market share of Poultry Live Attenuated Vaccine from 2021 to 2026.
Chapter 3, the Poultry Live Attenuated Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Poultry Live Attenuated Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Poultry Live Attenuated Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Poultry Live Attenuated Vaccine.
Chapter 14 and 15, to describe Poultry Live Attenuated Vaccine sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Poultry Live Attenuated Vaccine Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 NDV
- 1.3.3 Marek ' s Disease
- 1.3.4 IBD
- 1.3.5 Infectious Bronchitis
- 1.3.6 Influenza
- 1.3.7 Other
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Poultry Live Attenuated Vaccine Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Chicken
- 1.4.3 Other Poultry
- 1.5 Global Poultry Live Attenuated Vaccine Market Size & Forecast
- 1.5.1 Global Poultry Live Attenuated Vaccine Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Poultry Live Attenuated Vaccine Sales Quantity (2021-2032)
- 1.5.3 Global Poultry Live Attenuated Vaccine Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 MERCK
- 2.1.1 MERCK Details
- 2.1.2 MERCK Major Business
- 2.1.3 MERCK Poultry Live Attenuated Vaccine Product and Services
- 2.1.4 MERCK Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 MERCK Recent Developments/Updates
- 2.2 Boehringer Ingelheim
- 2.2.1 Boehringer Ingelheim Details
- 2.2.2 Boehringer Ingelheim Major Business
- 2.2.3 Boehringer Ingelheim Poultry Live Attenuated Vaccine Product and Services
- 2.2.4 Boehringer Ingelheim Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Boehringer Ingelheim Recent Developments/Updates
- 2.3 CEVA
- 2.3.1 CEVA Details
- 2.3.2 CEVA Major Business
- 2.3.3 CEVA Poultry Live Attenuated Vaccine Product and Services
- 2.3.4 CEVA Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 CEVA Recent Developments/Updates
- 2.4 ZOETIS
- 2.4.1 ZOETIS Details
- 2.4.2 ZOETIS Major Business
- 2.4.3 ZOETIS Poultry Live Attenuated Vaccine Product and Services
- 2.4.4 ZOETIS Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 ZOETIS Recent Developments/Updates
- 2.5 Vaxxinova
- 2.5.1 Vaxxinova Details
- 2.5.2 Vaxxinova Major Business
- 2.5.3 Vaxxinova Poultry Live Attenuated Vaccine Product and Services
- 2.5.4 Vaxxinova Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Vaxxinova Recent Developments/Updates
- 2.6 ELANCO
- 2.6.1 ELANCO Details
- 2.6.2 ELANCO Major Business
- 2.6.3 ELANCO Poultry Live Attenuated Vaccine Product and Services
- 2.6.4 ELANCO Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 ELANCO Recent Developments/Updates
- 2.7 QYH BIOTECH
- 2.7.1 QYH BIOTECH Details
- 2.7.2 QYH BIOTECH Major Business
- 2.7.3 QYH BIOTECH Poultry Live Attenuated Vaccine Product and Services
- 2.7.4 QYH BIOTECH Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 QYH BIOTECH Recent Developments/Updates
- 2.8 PULIKE
- 2.8.1 PULIKE Details
- 2.8.2 PULIKE Major Business
- 2.8.3 PULIKE Poultry Live Attenuated Vaccine Product and Services
- 2.8.4 PULIKE Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 PULIKE Recent Developments/Updates
- 2.9 PHIBRO ANIMAL HEALTH CORPORATION
- 2.9.1 PHIBRO ANIMAL HEALTH CORPORATION Details
- 2.9.2 PHIBRO ANIMAL HEALTH CORPORATION Major Business
- 2.9.3 PHIBRO ANIMAL HEALTH CORPORATION Poultry Live Attenuated Vaccine Product and Services
- 2.9.4 PHIBRO ANIMAL HEALTH CORPORATION Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 PHIBRO ANIMAL HEALTH CORPORATION Recent Developments/Updates
- 2.10 HARBIN PHARMACEUTICAL GROUP
- 2.10.1 HARBIN PHARMACEUTICAL GROUP Details
- 2.10.2 HARBIN PHARMACEUTICAL GROUP Major Business
- 2.10.3 HARBIN PHARMACEUTICAL GROUP Poultry Live Attenuated Vaccine Product and Services
- 2.10.4 HARBIN PHARMACEUTICAL GROUP Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 HARBIN PHARMACEUTICAL GROUP Recent Developments/Updates
- 2.11 MEVAC
- 2.11.1 MEVAC Details
- 2.11.2 MEVAC Major Business
- 2.11.3 MEVAC Poultry Live Attenuated Vaccine Product and Services
- 2.11.4 MEVAC Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 MEVAC Recent Developments/Updates
- 2.12 VENKY’S
- 2.12.1 VENKY’S Details
- 2.12.2 VENKY’S Major Business
- 2.12.3 VENKY’S Poultry Live Attenuated Vaccine Product and Services
- 2.12.4 VENKY’S Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 VENKY’S Recent Developments/Updates
- 2.13 Dechra
- 2.13.1 Dechra Details
- 2.13.2 Dechra Major Business
- 2.13.3 Dechra Poultry Live Attenuated Vaccine Product and Services
- 2.13.4 Dechra Poultry Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.13.5 Dechra Recent Developments/Updates
3 Competitive Environment: Poultry Live Attenuated Vaccine by Manufacturer
- 3.1 Global Poultry Live Attenuated Vaccine Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Poultry Live Attenuated Vaccine Revenue by Manufacturer (2021-2026)
- 3.3 Global Poultry Live Attenuated Vaccine Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Poultry Live Attenuated Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Poultry Live Attenuated Vaccine Manufacturer Market Share in 2025
- 3.4.3 Top 6 Poultry Live Attenuated Vaccine Manufacturer Market Share in 2025
- 3.5 Poultry Live Attenuated Vaccine Market: Overall Company Footprint Analysis
- 3.5.1 Poultry Live Attenuated Vaccine Market: Region Footprint
- 3.5.2 Poultry Live Attenuated Vaccine Market: Company Product Type Footprint
- 3.5.3 Poultry Live Attenuated Vaccine Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Poultry Live Attenuated Vaccine Market Size by Region
- 4.1.1 Global Poultry Live Attenuated Vaccine Sales Quantity by Region (2021-2032)
- 4.1.2 Global Poultry Live Attenuated Vaccine Consumption Value by Region (2021-2032)
- 4.1.3 Global Poultry Live Attenuated Vaccine Average Price by Region (2021-2032)
- 4.2 North America Poultry Live Attenuated Vaccine Consumption Value (2021-2032)
- 4.3 Europe Poultry Live Attenuated Vaccine Consumption Value (2021-2032)
- 4.4 Asia-Pacific Poultry Live Attenuated Vaccine Consumption Value (2021-2032)
- 4.5 South America Poultry Live Attenuated Vaccine Consumption Value (2021-2032)
- 4.6 Middle East & Africa Poultry Live Attenuated Vaccine Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Poultry Live Attenuated Vaccine Sales Quantity by Type (2021-2032)
- 5.2 Global Poultry Live Attenuated Vaccine Consumption Value by Type (2021-2032)
- 5.3 Global Poultry Live Attenuated Vaccine Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Poultry Live Attenuated Vaccine Sales Quantity by Application (2021-2032)
- 6.2 Global Poultry Live Attenuated Vaccine Consumption Value by Application (2021-2032)
- 6.3 Global Poultry Live Attenuated Vaccine Average Price by Application (2021-2032)
7 North America
- 7.1 North America Poultry Live Attenuated Vaccine Sales Quantity by Type (2021-2032)
- 7.2 North America Poultry Live Attenuated Vaccine Sales Quantity by Application (2021-2032)
- 7.3 North America Poultry Live Attenuated Vaccine Market Size by Country
- 7.3.1 North America Poultry Live Attenuated Vaccine Sales Quantity by Country (2021-2032)
- 7.3.2 North America Poultry Live Attenuated Vaccine Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Poultry Live Attenuated Vaccine Sales Quantity by Type (2021-2032)
- 8.2 Europe Poultry Live Attenuated Vaccine Sales Quantity by Application (2021-2032)
- 8.3 Europe Poultry Live Attenuated Vaccine Market Size by Country
- 8.3.1 Europe Poultry Live Attenuated Vaccine Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Poultry Live Attenuated Vaccine Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Poultry Live Attenuated Vaccine Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Poultry Live Attenuated Vaccine Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Poultry Live Attenuated Vaccine Market Size by Region
- 9.3.1 Asia-Pacific Poultry Live Attenuated Vaccine Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Poultry Live Attenuated Vaccine Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Poultry Live Attenuated Vaccine Sales Quantity by Type (2021-2032)
- 10.2 South America Poultry Live Attenuated Vaccine Sales Quantity by Application (2021-2032)
- 10.3 South America Poultry Live Attenuated Vaccine Market Size by Country
- 10.3.1 South America Poultry Live Attenuated Vaccine Sales Quantity by Country (2021-2032)
- 10.3.2 South America Poultry Live Attenuated Vaccine Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Poultry Live Attenuated Vaccine Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Poultry Live Attenuated Vaccine Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Poultry Live Attenuated Vaccine Market Size by Country
- 11.3.1 Middle East & Africa Poultry Live Attenuated Vaccine Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Poultry Live Attenuated Vaccine Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Poultry Live Attenuated Vaccine Market Drivers
- 12.2 Poultry Live Attenuated Vaccine Market Restraints
- 12.3 Poultry Live Attenuated Vaccine Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Poultry Live Attenuated Vaccine and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Poultry Live Attenuated Vaccine
- 13.3 Poultry Live Attenuated Vaccine Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Poultry Live Attenuated Vaccine Typical Distributors
- 14.3 Poultry Live Attenuated Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Poultry Live Attenuated Vaccine. Industry analysis & Market Report on Poultry Live Attenuated Vaccine is a syndicated market report, published as Global Poultry Live Attenuated Vaccine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Poultry Live Attenuated Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
